NCT01978067

Brief Summary

The aim of this study is to further demonstrate the safety , validity and quality of (sexual)life of vaginal operation for previous cesarean scar defect resection.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 31, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 7, 2013

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

February 27, 2014

Status Verified

February 1, 2014

Enrollment Period

2.9 years

First QC Date

October 31, 2013

Last Update Submit

February 26, 2014

Conditions

Keywords

Uterine Scar From Previous Cesarean Deliveryprevious caesarean scar deficiencytransvaginal resectionquality of lifesexual activity

Outcome Measures

Primary Outcomes (1)

  • The safety of transvaginal resection of caesarean scar deficiency in the treatment of PCSD

    blood loss, hemoglobin in the first postoperative day, operation time, preoperative and postoperative complications,change to other treatment,vaginal bleeding after surgery and length of stay are collected to evaluate the safety of this procedure.

    one week

Secondary Outcomes (1)

  • the effectiveness of transvaginal resection of caesarean scar deficiency in the treatment of PCSD.

    one year

Other Outcomes (1)

  • the result of transvaginal resection of caesarean scar deficiency in affecting quality of (sex)life.

    one year

Study Arms (1)

transvaginal resection of Uterine Scar

transvaginal resection of Uterine Scar From Previous Cesarean Delivery

Procedure: transvaginal resection of Uterine Scar

Interventions

Expose, grasp and traction the cervix. An incision was made at the anterior cervicovaginal junction, and the bladder was dissected away until the anterior peritoneal reflection was identified. The anterior drawing hook was inserted.into the vaginal incision to retract the bladder upwards. The PCSD was identified as a'fornix' located in the anterior part of the lower uterine segment. A transverse incision was made to remove the scar deficiency, and the edges of the incision were trimmed with scissors, and the myometrial and vaginal defects were closed.

transvaginal resection of Uterine Scar

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

60 patients diagnosed PCSD scheduled for vaginal operation in The First Affiliated Hospital between December 2013 and December 2015

You may qualify if:

  • preoperative diagnosed as PCSD
  • hemodynamic stability

You may not qualify if:

  • irregular menstrual cycle
  • using IUD
  • complicating other disease also causing vaginal bleeding,such as endometrial polyp,submucous myoma and functional uterine bleeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, 510080, China

RECRUITING

MeSH Terms

Conditions

Sexual Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Chen Shu-Qin, M.D&PhD

    First Affiliated Hospital, Sun Yat-Sen University

    STUDY DIRECTOR
  • Yao Shu-Zhong, M.D&Ph.D

    First Affiliated Hospital, Sun Yat-Sen University

    STUDY CHAIR
  • Fan Li, M.D

    First Affiliated Hospital, Sun Yat-Sen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chen Shu-Qin, PhD & MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
associate professor of gynaecology and obstetricsf

Study Record Dates

First Submitted

October 31, 2013

First Posted

November 7, 2013

Study Start

January 1, 2013

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

February 27, 2014

Record last verified: 2014-02

Locations